Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14932025 | 0.86 | PNMT (0.35) | PNMTNPC1RAB9A | |
| Hydrochloric Acid SCHEMBL28554371 | 0.84 | PNMT (0.33) | PNMTNPC1RAB9AHTR7HTR2B | |
| Methane SCHEMBL5838735 | 0.82 | PNMT (0.38) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL6557797 | 0.81 | PNMT (0.39) | PNMTNPC1RAB9AHTR7HTR2B | |
| Hydrochloric Acid SCHEMBL6559527 | 0.80 | PNMT (0.38) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL8413656 | 0.80 | PNMT (0.38) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL4469957 | 0.78 | NPC1 (0.45) | PNMTNPC1RAB9AHTR7HTR2B | |
| SCHEMBL6433465 | 0.78 | NPC1 (0.37) | PNMTNPC1RAB9AHTR7HTR2B | |
| Hydrochloric Acid SCHEMBL6302943 | 0.77 | NPC1 (0.44) | PNMTNPC1RAB9AHTR7HTR2B | |
| Hydrochloric Acid SCHEMBL7634665 | 0.77 | NPC1 (0.44) | PNMTNPC1RAB9AHTR7HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7074736-B2 | Hydrozirconated matrix and process for polyolefin production | ROHM AND HAAS COMPANY (US) | 2006-07-11 | — | — | US | claimed |
| EP-1201684-A2 | Hydrozirconated matrix and process for polyolefin production | ROHM AND HAAS COMPANY (US) | 2002-05-02 | — | — | EP | claimed |
| US-20020052536-A1 | Hydrozirconated matrix and process for polyolefin production | ROHM AND HAAS COMPANY | 2002-05-02 | — | — | US | claimed |
| US-7074736-B2 | Hydrozirconated matrix and process for polyolefin production | ROHM AND HAAS COMPANY (US) | 2006-07-11 | — | — | US | disclosed |
| US-20020052536-A1 | Hydrozirconated matrix and process for polyolefin production | ROHM AND HAAS COMPANY | 2002-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052536-A1 | Hydrozirconated matrix and process for polyolefin production | HOGA1, PPIP5K2, HPD | PNMT 868/4885NPC1 3687/4885RAB9A 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.